Form 4: Moderna President Sells Shares
Insider Transaction (Form 4)
Stephen Hoge, President of Moderna, Inc., sold 78,369 shares of common stock on October 14, 2026.
Summary
- Option exercise/conversion: acquired 76,453 Common Stock at $12.21 ($933,491) on October 14, 2026; holds 1,638,482 after (Direct).
- Open-market sale: disposed of 38,774 Common Stock at $213.47 ($8,277,086) on October 14, 2026; holds 1,599,708 after (Direct).
- Open-market sale: disposed of 450 Common Stock at $214.15 ($96,368) on October 14, 2026; holds 1,599,258 after (Direct).
- Option exercise/conversion: acquired 76,452 Common Stock at $12.21 ($933,479) on October 15, 2026; holds 1,675,710 after (Direct).
- Open-market sale: disposed of 39,145 Common Stock at $220.72 ($8,640,084) on October 15, 2026; holds 1,636,565 after (Direct).
- Option exercise/conversion: disposed of 76,453 Stock Option (Right to Buy) on October 14, 2026; holds 229,357 after (Direct).
- Option exercise/conversion: disposed of 76,452 Stock Option (Right to Buy) on October 15, 2026; holds 152,905 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $17,013,538 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Stephen Hoge — Officer (President)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-14 | Option exercise/conversion | Common Stock | 76,453 | $12 | $933.5K | 1,638,482 |
| 2026-10-14 | Open-market sale | Common Stock | 38,774 | $213 | $8.3M | 1,599,708 |
| 2026-10-14 | Open-market sale | Common Stock | 450 | $214 | $96.4K | 1,599,258 |
| 2026-10-15 | Option exercise/conversion | Common Stock | 76,452 | $12 | $933.5K | 1,675,710 |
| 2026-10-15 | Open-market sale | Common Stock | 39,145 | $221 | $8.6M | 1,636,565 |
| 2026-10-14 | Option exercise/conversion | Stock Option (Right to Buy) | 76,453 | — | — | 229,357 |
| 2026-10-15 | Option exercise/conversion | Stock Option (Right to Buy) | 76,452 | — | — | 152,905 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-14 | Option exercise/conversion (76,453 shares) |
| 2026-10-14 | Open-market sale (38,774 shares) |
| 2026-10-14 | Open-market sale (450 shares) |
| 2026-10-15 | Option exercise/conversion (76,452 shares) |
| 2026-10-15 | Open-market sale (39,145 shares) |
| 2026-10-14 | Option exercise/conversion (76,453 shares) |
| 2026-10-15 | Option exercise/conversion (76,452 shares) |
Keywords
insider transaction, Form 4, MRNA, Moderna, Inc., bearish, Stephen Hoge
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.